Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Shore

Showing results (41-50 of 312) with videos related to

Pageof 32
Sort By:
Urologic Oncology|July 17, 2012
The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. IntroductionDaniel W Lin, Neal D Shore
The New England Journal of Medicine|April 22, 2026
Enzalutamide in Biochemically Recurrent Prostate Cancer. ReplyNeal D Shore, Stephen J Freedland
Urology Practice|August 3, 2023
Proper Sequencing of Treatment for Castrate Resistant Prostate CancerNeal D Shore, Michael S Cookson
Reviews in Urology|September 30, 2017
The society of urologic oncology clinical trials consortium: A brief history and overviewNeal D Shore, Colin Dinney, Robert Uzzo
BJU International|March 4, 2024
Complications of immuno-oncology care: what urologist should knowValentina Grajales, Alberto Martini, Neal D Shore
Postgraduate Medicine|November 9, 2013
A urologic oncology roundtable discussion: how to choose among the available therapies for the treatment of castration-resistant prostate cancerCharles Ryan, Neal D Shore, Raoul Concepcion
European Urology|August 26, 2020
Reply to Brandon A. Mahal, Anthony V. D'Amico, and Paul L. Nguyen's Letter to the Editor re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96Neal D Shore, David Dearnaley, Bertrand Tombal
The New England Journal of Medicine|January 3, 2024
Enzalutamide in Biochemically Recurrent Prostate Cancer. ReplyNeal D Shore, Jamal Tarazi, Stephen J Freedland
Hospital Practice (1995)|October 23, 2013
A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancerNeal D Shore, Raoul Concepcion, Daniel A Barocas
Current Treatment Options in Oncology|January 29, 2024
Updates on Management of Biochemical Recurrent Prostate CancerLauren Folgosa Cooley, Abhishek Srivastava, Neal D Shore
Pageof 32

Showing results (41-50 of 312) with videos related to

Sort By:
Pageof 32
Urologic Oncology|July 17, 2012
The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. IntroductionDaniel W Lin, Neal D Shore
The New England Journal of Medicine|April 22, 2026
Enzalutamide in Biochemically Recurrent Prostate Cancer. ReplyNeal D Shore, Stephen J Freedland
Urology Practice|August 3, 2023
Proper Sequencing of Treatment for Castrate Resistant Prostate CancerNeal D Shore, Michael S Cookson
Reviews in Urology|September 30, 2017
The society of urologic oncology clinical trials consortium: A brief history and overviewNeal D Shore, Colin Dinney, Robert Uzzo
BJU International|March 4, 2024
Complications of immuno-oncology care: what urologist should knowValentina Grajales, Alberto Martini, Neal D Shore
Postgraduate Medicine|November 9, 2013
A urologic oncology roundtable discussion: how to choose among the available therapies for the treatment of castration-resistant prostate cancerCharles Ryan, Neal D Shore, Raoul Concepcion
European Urology|August 26, 2020
Reply to Brandon A. Mahal, Anthony V. D'Amico, and Paul L. Nguyen's Letter to the Editor re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96Neal D Shore, David Dearnaley, Bertrand Tombal
The New England Journal of Medicine|January 3, 2024
Enzalutamide in Biochemically Recurrent Prostate Cancer. ReplyNeal D Shore, Jamal Tarazi, Stephen J Freedland
Hospital Practice (1995)|October 23, 2013
A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancerNeal D Shore, Raoul Concepcion, Daniel A Barocas
Current Treatment Options in Oncology|January 29, 2024
Updates on Management of Biochemical Recurrent Prostate CancerLauren Folgosa Cooley, Abhishek Srivastava, Neal D Shore
Pageof 32